(Q37109205)

18 August 2017

1 reference

title

Adynamic bone in patients with chronic kidney disease (English)

1 reference

18 August 2017

0 references

D L Andress

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

12 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

73

1 reference

18 August 2017

issue

12

1 reference

18 August 2017

page(s)

1345-1354

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2008.60

18 August 2017

exact match

0 references

cites work

The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

The spectrum of bone disease in end-stage renal failure--an evolving disorder

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Evidence for abnormal calcium homeostasis in patients with adynamic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Arterial calcifications and bone histomorphometry in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

On the evolving nature of understanding dialysis-related disorders

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Mortality risk among hemodialysis patients receiving different vitamin D analogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Survival following parathyroidectomy among United States dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Bone remodeling rate and remodeling balance are not co-regulated in adulthood: implications for the use of activation frequency as an index of remodeling rate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Inter-observer and intra-observer variation in bone histomorphometry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Tetracycline double-labeling of iliac trabecular bone in 41 normal adults.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Osteocalcin and bone morphometric parameters in adults without bone disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Significance of minimodeling in dialysis patients with adynamic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Increased bone mineral density in patients with chronic hypoparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

The effects of acid on bone

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Differential effects of androgens and estrogens on bone turnover in normal men.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Plasma insulin-like growth factors and bone formation in uremic hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Reversal of adynamic bone disease by lowering of dialysate calcium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Mechanism of vitamin D action and its regulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Parathyroid hormone decreases renal vitamin D receptor expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Noncalcemic Actions of Vitamin D Receptor Ligands

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Metabolic acidosis suppresses 25-hydroxyvitamin in D3-1alpha-hydroxylase in the rat kidney. Distinct site and mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Decreased in vitro osteoblast proliferation and low turnover bone disease in nonuremic proteinuric patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Growth hormone and adult bone remodelling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Sex steroids and the construction and conservation of the adult skeleton

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Reversal of bone loss in mice by nongenotropic signaling of sex steroids

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Bone changes and carotid atherosclerosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Aortic calcification and the risk of osteoporosis and fractures

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Estrogen therapy and coronary-artery calcification.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Quantifying osteoblast and osteocyte apoptosis: challenges and rewards

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Risk factors for vertebral fractures in renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Historical background and clinical treatment of dialysis-related amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Increased risk of hip fracture among patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Fracture risk after parathyroidectomy among chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Elective total parathyroidectomy without autotransplant in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Aluminum posttranscriptional regulation of parathyroid hormone synthesis: a role for the calcium-sensing receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Phosphorus balance and mineral metabolism with 3 h daily hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

1,25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene's transcriptional start site

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Vitamin D Action and Regulation of Bone Remodeling: Suppression of Osteoclastogenesis by the Mature Osteoblast

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

ED-71, a novel vitamin D analog, promotes bone formation and angiogenesis and inhibits bone resorption after bone marrow ablation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Effects of oral calcitriol on bone mineral density in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Differential effects of Vitamin D analogs on bone formation and resorption

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

1 alpha,25-dihydroxyvitamin D3 increases IGF binding protein-5 expression in cultured osteoblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Evidence that IGF-binding protein-5 functions as a growth factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Association of activated vitamin D treatment and mortality in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Immunologic function and survival in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Protective Role of Interleukin-10 in Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

The macrophage foam cell as a target for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Improving quality of care for urban older people with diabetes mellitus and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Testosterone metabolism and replacement therapy in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Prescription of hormone replacement therapy in postmenopausal women with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Ovariectomy worsens secondary hyperparathyroidism in mature rats during low-Ca diet

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Special aspects of renal osteodystrophy in children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Stimulating growth in uremic children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Increased Growth after Long-Term Oral 1α,25-Vitamin D3in Childhood Renal Osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.60

7 January 2021

Identifiers

DOI

10.1038/KI.2008.60

1 reference

Dimensions Publication ID

18 August 2017

1024804912

0 references

1 reference